US Patent 11311519 Treatment of hepatitis delta virus infection
Patent 11311519 was granted and assigned to Eiger BioPharmaceuticals on April, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11311519 Treatment of hepatitis delta virus infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.